Sorbent Therapeutics Obtains $36,000,000 Series B Financing Round

  • Feed Type
  • Date
    6/30/2011
  • Company Name
    Sorbent Therapeutics
  • Mailing Address
    710 Lakeway Drive Sunnyvale, CA 94085
  • Company Description
    Sorbent Therapeutics is a biopharmaceutical company focused on the development of adaptable non-absorbed polymeric drugs to satisfy unmet clinical needs in large markets such as End Stage Renal Disease (ESRD), Congestive Heart Failure (CHF), Chronic Kidney Disease (CKD), and Hypertension.
  • Website
    http://www.sorbentrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $36,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The financing will enable Sorbent to complete Phase 2 for its lead program in heart failure, CLP1001.
  • M&A Terms
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    CMEA Ventures
  • Venture Investor
    AgeChem Venture Fund

By posting a comment, you agree to our terms and conditions.